Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01896778
What this trial is testing

Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

Who this might be right for
Adult Liver CarcinomaBreast CarcinomaColon Carcinoma+7 more
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)WithdrawnNCT04909515
What this trial is testing

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.

Who this might be right for
Neuroblastoma
Y-mAbs Therapeutics
Testing effectiveness (Phase 2)Looking for participantsNCT07391215
What this trial is testing

5G-PEARL: Paxalisib in Malignant Brain Tumours

Who this might be right for
Malignant Primary GliomasGlioblastoma Multiforme (GBM)
Institute of Cancer Research, United Kingdom 64
Early research (Phase 1)Ended earlyNCT01106235
What this trial is testing

Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma

Who this might be right for
Stage IV Melanoma
Fred Hutchinson Cancer Center 12
Large-scale testing (Phase 3)Looking for participantsNCT03126916
What this trial is testing

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Who this might be right for
GanglioneuroblastomaGanglioneuroblastoma, NodularNeuroblastoma
Children's Oncology Group 750
Not applicableStudy completedNCT06038604
What this trial is testing

Glioblastoma Psychosocial Support Program

Who this might be right for
Glioblastoma
Duke University 11
Very early researchUnknownNCT01620749
What this trial is testing

Of 18F MEL050 Using PET/CT in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Cooperative Research Centre for Biomedical Imaging Development 12
Very early researchLooking for participantsNCT04655404
What this trial is testing

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Who this might be right for
High Grade GliomaDiffuse Intrinsic Pontine Glioma
Nationwide Children's Hospital 15
Testing effectiveness (Phase 2)Study completedNCT06151847
What this trial is testing

Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+1 more
University of Kansas Medical Center 11
Very early researchLooking for participantsNCT07493447
What this trial is testing

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Who this might be right for
MeningiomaGlioblastomaAcoustic Neuroma+2 more
Eben Rosenthal 30
Early research (Phase 1)Ended earlyNCT02240758
What this trial is testing

Confocal Laser Endomicroscopy for Brain Tumors

Who this might be right for
Low Grade Glioma (LGG), High Grade Glioma (HGG)
Hospices Civils de Lyon 10
Testing effectiveness (Phase 2)Ended earlyNCT01986348
What this trial is testing

Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

Who this might be right for
GlioblastomaGlioma
Karyopharm Therapeutics Inc 76
Post-approval studies (Phase 4)Study completedNCT01794793
What this trial is testing

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Who this might be right for
Cushing's DiseaseAcromegalyNeuroendocrine Tumors+6 more
RECORDATI GROUP 337
Not applicableStudy completedNCT00010114
What this trial is testing

Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children

Who this might be right for
Central Nervous System Embryonal Neoplasm
Pediatric Brain Tumor Consortium 83
Testing effectiveness (Phase 2)Study completedNCT02114658
What this trial is testing

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Who this might be right for
Thyroid Carcinoma
Bayer 18
Not applicableNot Yet RecruitingNCT07333326
What this trial is testing

Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole

Who this might be right for
Gestational Trophoblastic NeoplasiaComplete Hydatiform Mole
Minia University 175
Testing effectiveness (Phase 2)Ended earlyNCT00062504
What this trial is testing

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Teva Branded Pharmaceutical Products R&D, Inc. 30
Early research (Phase 1)Enrolling By InvitationNCT06424626
What this trial is testing

A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma

Who this might be right for
MelanomaMucosal MelanomaMetastatic Melanoma
Peking University Cancer Hospital & Institute 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02858921
What this trial is testing

Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 60
Testing effectiveness (Phase 2)Study completedNCT00423852
What this trial is testing

Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
Memorial Sloan Kettering Cancer Center 26
Next Page